Skip to main content
. Author manuscript; available in PMC: 2018 Mar 28.
Published in final edited form as: Clin Cancer Res. 2016 Nov 16;23(6):1407–1413. doi: 10.1158/1078-0432.CCR-16-1936

Fig. 1.

Fig. 1

Schematic of core processes necessary for trial activation at MD Anderson Cancer Center and the general flow within the Department of Investigational Cancer Therapeutics to achieve each step.